Clinical Trial Update: Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial [Phase 2]

View source ↗

Summary

A Phase II trial evaluating perioperative toripalimab and endostatin for stage II melanoma is currently recruiting, sponsored by Fudan University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acral Melanoma
• Melanoma

Drugs mentioned

• Endostatin (endostatin)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Fudan University | Conditions: Melanoma of Skin, Acral Melanoma | Phase 2 | Status: RECRUITING